St. Louis court clears way for first Infuse jury trial
A St. Louis judge has cleared the way for the first jury trial involving personal injuries allegedly caused by Medtronic’s Infuse Bone Graft.
The injury claims of plaintiff Trisha Keim are set for trial in February, after Judge Mark H. Neill of …
— StarTribune Business (@StribBiz) December 9, 2016
Patients who received Medtronic’s Infuse product to get $8.45 million in settlements
Two patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …
In letter to Franken, FDA defends handling of Medtronic’s Infuse study
After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.
He called for “a more robust, proactive medical device …
Original article here
— Heath Care News (@hc_equipment) December 9, 2016
FDA hearing on off-labels use of devices explores risks to patients
First, health policy expert Diana Zuckerman displayed huge photos of the disfigured, bruised faces of two babies who had been implanted with Medtronic’s Infuse Bone Graft product in their skulls.
Then Zuckerman, who is president of the National Center …
Ohio judge dismisses hundreds of off-label Medtronic Infuse patient lawsuits
US district court judge, Timothy S Black (Southern Ohio, USA) has dismissed the accusation of several hundred plaintiffs that they have been treated off-label with Medtronic’s Infuse.
The plaintiffs were all former patients of Atiq Durrani …
Medtronic Disentangles Itself From Durrani Infuse Lawsuits
Spine patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.
Durrani is currently practicing back surgery on Pakistanis after …
Court Denies All Medtronic Summary Requests in Infuse Litigation
Parker Waichman LLP notes a significant loss for medical device manufacturer, Medtronic, Inc.
Judge Mark H. Neill of St. Louis’ 22nd Judicial Circuit has ruled that the company’s Infuse medical device may have been …
Read the original article here
— Gerätor (@GeratorTrdplc) December 8, 2016
Medtronic headaches resurface as patients awarded $8.45 Million
This past month marks a pivotal decision in the ongoing litigation over the Medtronic bone graft product, Infuse, as two patients injured by Medtronic’s product will receive a combined $8.45 million in settlements—not from the manufacturers of the …
A look behind the Star Tribune’s special report on Medtronic, ‘A Question of Risk’
The Sunday before last, the Star Tribune published a front-page story laying out how Medtronic, one the area’s highest profile corporations, “misfiled” a report on adverse reactions to the company’s lucrative but problematic bone fusion device, Infuse.
Read the full story here
Sen. Franken pushes for review of Medtronic Infuse study – Mass Device
Medtronic InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product may have “potentially skewed the risk profile” for patients and exposed “insufficient vigilance …